Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has completed the acquisition of the branded over-the-counter (OTC) rights to Prevacid®24HR.
Jeff Needham, Executive Vice President and President Consumer Self-Care Americas said, “The closing of this tuck-in transaction expands our U.S. OTC presence with a leading brand in the digestive health category and enhances our leadership position in this strategically important category. I am confident that we can accelerate the growth of this margin accretive brand, as well as the total category by leveraging Perrigo’s commercial infrastructure, including our manufacturing expertise, R&D capabilities and expansive customer network.”
Prevacid®24HR treats frequent heartburn (occurring 2 or more days a week) and is not intended for immediate relief of heartburn.
Source: BioSpace
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.